Publications & Presentations

We would like to thank our patients for their participation in research studies. Your contribution has made a lasting impact on the field and will advance the care of future patients!

Selected Publications and Presentations

• Racial and Ethnic Distribution of Rheumatic Diseases in Health Systems of the National Patient-Centered Clinical Research Network
• A Care Coordination Model to Prevent Cardiovascular Events in Patients with Psoriatic Disease: A Multicenter Pilot Study
• Use of the BASDAI in Psoriatic Arthritis Patients With and Without Axial Disease
• The impact of dietary interventions in psoriatic arthritis
• H. Ralph Schumacher
• Corticosteroid Injections for Symptomatic Treatment of Osteoarthritis of the Knee: A Pilot Blinded Randomized Trial
• Associations between Adiponectin and the Development of Diabetes in Rheumatoid Arthritis
• Lower body mass and lower adiposity are associated with differential responses to two treatment strategies for rheumatoid arthritis
• Changes in Patterns of Use of Advanced Therapies Following Emerging Data About Adverse Events in Patients With Rheumatoid Arthritis From the Veterans Affairs Health System
• Identifying Factors Associated With Treatment Response in Rheumatoid Arthritis Clinical Trials
• Risk of Biologics and Glucocorticoids in Patients With Rheumatoid Arthritis Undergoing Arthroplasty: A Cohort Study

PubMed Feed

• Association of immune checkpoint inhibitors with muscle mass and density in patients with melanoma.
  The oncologist. 2026 Feb 12; Authors: Ziolkowski S, Matheson BE, Boyd SK, Walle M, Gill J, Walker J, Salopek T, Baker JF, Fettahoglu A, Ye C

• Efficacy and Safety of Guselkumab in Participants with Active Psoriatic Arthritis After Inadequate Response to One Prior Tumor Necrosis Factor Inhibitor: Week-24 Results of the Phase 3, Randomized, Placebo-Controlled SOLSTICE Study.
  Arthritis & rheumatology (Hoboken, N.J.). 2026 Feb 11; Authors: Ogdie A, Merola JF, Mease PJ, Ritchlin CT, Scher JU, Lafferty KP, Chan D, Chakravarty SD, Langholff W, Wang Y, Shao J, Krol Y, Gottlieb AB

• Performance of the Predicting Risk of Cardiovascular Disease EVENTs (PREVENT) Calculator in Rheumatoid Arthritis.
  Arthritis & rheumatology (Hoboken, N.J.). 2026 Feb 9; Authors: Johnson TM, Frideres H, Roul P, Baker JF, Sauer BC, Cannon GW, Smith ID, Kunkel GA, Wallace BI, Porter TR, Bookani KR, Annapureddy AR, Mikuls TR, England BR

• Immune Checkpoint Inhibitor Related Myositis and Associated Triad Overlap Syndrome.
  Arthritis care & research. 2026 Feb 9; Authors: Rubino S, Cannon GW, Sauer BC, Rojas J, Stoddard GJ, Kunkel GA, Walsh JA, England BR, Baker JF, Braaten TJ

• Evaluating a Pragmatic Strength Alternative for Frailty Measurement and Assessing its Predictive Capacity Against Established Frailty Instruments in Rheumatoid Arthritis.
  Arthritis care & research. 2026 Feb 8; Authors: Riggles KE, Brubeck HF, Tanus AD, Loecker CN, Roul P, England BR, Wahl ER, Andrews JS, Singh N, Baker JF, Katz PP, Shoback DM, Garcia JM, Orkaby AR, Wysham KD

• Heterogeneity in the association of genetic risk for RA and resultant RA phenotypes.
  Rheumatology (Oxford, England). 2026 Feb 4;65(2); Authors: Riley TR 4th, Wheeler AM, England BR, Cannon GW, Sauer B, Kunkel GA, Wysham KD, Wallace BI, Monach PA, Reimold A, Kerr GS, Smith ID, Richards JS, Lee I, Thiele GM, Xiao R, Damrauer SM, Levin MG, George MD, Mikuls TR, Baker JF

• Burden of Disease and Drug Response for Patients With Rheumatoid Arthritis by Shared Epitope and Anticitrullinated Protein Antibody Status.
  The Journal of rheumatology. 2026 Feb 1;53(2):144-151; Authors: Wipfler K, Baker JF, Sayles H, Park SH, Wittstock K, Mikuls TR, Michaud K

• Effectiveness of Tofacitinib in Patients with Psoriatic Arthritis Initiating Monotherapy Versus Combination Therapy: Results from the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry.
  Rheumatology and therapy. 2026 Feb;13(1):195-212 Epub 2025 Dec 4; Authors: Ogdie A, Middaugh N, Blachley T, Bourgeois T, Ling YL, Mundayat R, Fallon L, Masri KR, Mease PJ

• Influence of Biological Sex on Participant Characteristics, Guselkumab Efficacy and Radiographic Progression in Active Psoriatic Arthritis: Post Hoc Analysis of Three Randomized Trials.
  Rheumatology and therapy. 2026 Feb;13(1):213-229 Epub 2025 Dec 15; Authors: Gladman DD, Eder L, Selmi C, Mease PJ, Ogdie A, Lozenski K, Adamson E, Sharaf M, Rampakakis E, Pina Vegas L, Coates LC

• Loss of Lean Mass in Rheumatoid Arthritis Is Associated With Loss of Total and Visceral Fat.
  Journal of cachexia, sarcopenia and muscle. 2026 Feb;17(1):e70229; Authors: Baker JF, Giles JT, Zemel B, Wysham KD, Long J, Leonard M, Katz P